Evolution of the reagent market: how sensitivity demands and miniaturization shape the future
Lately I’ve noticed that almost every grant proposal or project pitch I’m involved with asks about sensitivity levels that would’ve been unthinkable five years ago. On top of that, everyone wants assays to be faster, smaller, and easier to use, almost like point-of-care devices. I remember running older ELISA plates where time wasn’t the biggest concern, but now the expectation is ultra-sensitive results in record time. How do you see this trend affecting what’s available in the market?
11 Views
I’ve seen the same shift. A few years ago, our lab switched to miniaturized PCR systems because space and reagent cost were both issues. The smaller systems actually gave us tighter control over sample volume and helped reduce waste, but it also meant we had to adapt our workflows. Companies are clearly responding to this demand—on sites like https://gentaur.co.uk/, you’ll find more compact diagnostic kits and reagents designed for high sensitivity with smaller inputs. It feels like we’re moving toward a future where portability and precision go hand in hand.